Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

NCT06745154 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-12-20

No results posted yet for this study

Summary

This clinical trial evaluates the impact of Quitting Using Executive Function Strategy Training (QUEST) on quitting smoking (cessation) in homeless young adult smokers with an acquired brain injury (ABI). Over 70% of youth and young adults experiencing homelessness (YYEH) smoke tobacco. More than half of YYEH who smoke have made at least one attempt to quit smoking but few use evidence-based methods to increase success. In addition, 9 out of 10 of these have an acquired brain injury which may have a negative impact on successful smoking cessation. QUEST may help homeless young adult smokers with an ABI quit smoking.

Conditions

  • Cigarette Smoking-Related Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo nasal swab collection

PROCEDURE

Cognitive Assessment

Undergo cognitive assessment

OTHER

Interview

Ancillary studies

DRUG

Nicotine Replacement

Given nicotine patches, gum, or lozenges

BEHAVIORAL

Smoking Cessation Intervention

Receive access to the Ohio Tobacco Quit Line

OTHER

Survey Administration

Ancillary studies

OTHER

Tobacco Cessation Counseling

Participate in counseling sessions

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Julianna Nemeth, PhD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-26
Primary Completion
2023-08-30
Completion
2023-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745154 on ClinicalTrials.gov